1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus

Bibliographic Details
Main Authors: Karen Costenbader, Yuqing Zhang, Hyon Choi, April Jorge, Emma Materne, Baijun Zhou
Format: Article
Language:English
Published: BMJ Publishing Group 2022-12-01
Series:Lupus Science and Medicine
_version_ 1811292611488514048
author Karen Costenbader
Yuqing Zhang
Hyon Choi
April Jorge
Emma Materne
Baijun Zhou
author_facet Karen Costenbader
Yuqing Zhang
Hyon Choi
April Jorge
Emma Materne
Baijun Zhou
author_sort Karen Costenbader
collection DOAJ
first_indexed 2024-04-13T04:48:57Z
format Article
id doaj.art-95e1136c532b4974af19e596870568fe
institution Directory Open Access Journal
issn 2053-8790
language English
last_indexed 2024-04-13T04:48:57Z
publishDate 2022-12-01
publisher BMJ Publishing Group
record_format Article
series Lupus Science and Medicine
spelling doaj.art-95e1136c532b4974af19e596870568fe2022-12-22T03:01:46ZengBMJ Publishing GroupLupus Science and Medicine2053-87902022-12-019Suppl 310.1136/lupus-2022-lupus21century.991604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus ErythematosusKaren Costenbader0Yuqing Zhang1Hyon Choi2April Jorge3Emma Materne4Baijun Zhou5Medicine, Brigham and Women`s Hospital, Boston, Massachusetts, USA2 Clinical Epidemiology Program, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA7 Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA1Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital3Department of Medicine, Massachusetts General Hospital1Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital
spellingShingle Karen Costenbader
Yuqing Zhang
Hyon Choi
April Jorge
Emma Materne
Baijun Zhou
1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus
Lupus Science and Medicine
title 1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus
title_full 1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus
title_fullStr 1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus
title_full_unstemmed 1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus
title_short 1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus
title_sort 1604 comparative risks of infection with belimumab versus oral immunosuppressants in patients with non renal systemic lupus erythematosus
work_keys_str_mv AT karencostenbader 1604comparativerisksofinfectionwithbelimumabversusoralimmunosuppressantsinpatientswithnonrenalsystemiclupuserythematosus
AT yuqingzhang 1604comparativerisksofinfectionwithbelimumabversusoralimmunosuppressantsinpatientswithnonrenalsystemiclupuserythematosus
AT hyonchoi 1604comparativerisksofinfectionwithbelimumabversusoralimmunosuppressantsinpatientswithnonrenalsystemiclupuserythematosus
AT apriljorge 1604comparativerisksofinfectionwithbelimumabversusoralimmunosuppressantsinpatientswithnonrenalsystemiclupuserythematosus
AT emmamaterne 1604comparativerisksofinfectionwithbelimumabversusoralimmunosuppressantsinpatientswithnonrenalsystemiclupuserythematosus
AT baijunzhou 1604comparativerisksofinfectionwithbelimumabversusoralimmunosuppressantsinpatientswithnonrenalsystemiclupuserythematosus